Test Price
2,800 AEDโ Home Collection Available
DRD2 Gene Sequencing for Myoclonic Dystonia in UAE | Premium NGS Diagnostics by DNA Labs UAE
Executive Summary & Core Metrics
Actionable Genetic Insights for Movement Disorders
This advanced sequencing test analyzes the DRD2 gene coding region using Next-Generation Sequencing (NGS) to detect pathogenic variants associated with myoclonic dystonia. Priced at 2,800 AED, the service includes pre-test genetic counseling, VIP mobile phlebotomy, ISO-certified cold-chain logistics, and a post-test telephonic consultation with a Consultant Medical Geneticist.
- Accuracy Guarantee: 99.9% diagnostic sensitivity for single-nucleotide variants and CNVs via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for comprehensive result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The DRD2 Gene Sequencing test employs Next-Generation Sequencing (NGS) to thoroughly interrogate the entire coding region and intron-exon boundaries of the DRD2 gene. This ensures comprehensive detection of single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variations (CNVs) linked to myoclonic dystonia (DYT11).
Why Our NGS Approach Leads the UAE Market?
| Feature | DNA Labs UAE (DHA/MOHAP) | Closest Alternative |
|---|---|---|
| Precision | 99.9% single-nucleotide & CNV detection via NGS | Standard Sanger sequencing (single exon focus) |
| Methodology | NGS with integrated bioinformatics CNV analysis | Fragmented gene panels or single-exon analysis |
| Turnaround | 3โ4 Weeks, cold-chain assured logistics | 4โ6 Weeks, no home collection |
| Clinical Support | Pre & post-test genetic counseling included | Report-only delivery |
Physician Insight & Safety Protocols
โThe DRD2 NGS test represents a significant advancement in precision medicine for movement disorders. As a Consultant Medical Geneticist, I emphasize that while this test provides a definitive molecular diagnosis for myoclonic dystonia, results must always be integrated with a thorough clinical evaluation and neurological examination. Genetic counseling is essential both before and after testing to ensure patients and their families fully understand the implications of the findings.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Advisory: Medication & Clinical Management
Genetic test results provide diagnostic and risk information but do not replace clinical judgment. Patients should not alter or discontinue prescribed medications without explicit instructions from their treating neurologist. The detection of a pathogenic variant is not an immediate directive for therapeutic change.
Safety Exclusion & Red Flags
- Exclusion Criteria: Inability to provide informed consent, acute psychiatric instability preventing effective genetic counseling, or active coagulopathy precluding a safe peripheral blood draw.
- Emergency Red Flags: This test is not intended for acute crisis management. If you experience sudden severe muscle contractions, respiratory distress, or loss of consciousness, seek immediate emergency medical care.
- Minors: Testing for individuals under 18 requires legal guardian consent and is conducted in full compliance with Federal Decree-Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019.
Patient FAQ & Clinical Guidance
1. What is the primary purpose of the DRD2 gene sequencing test?
Answer: The test is designed to identify pathogenic variants in the DRD2 gene that are causally linked to myoclonic dystonia (DYT11). It provides a definitive molecular diagnosis to guide targeted neurological management, genetic counseling, and family planning decisions.
2. What does the 2,800 AED price comprehensively cover?
Answer: The 2,800 AED fee covers the complete NGS laboratory analysis of the DRD2 gene, a pre-test genetic counseling session, VIP mobile phlebotomy at your home, temperature-controlled sample transportation to our DHA-licensed laboratory, and a structured post-test telephonic consultation with a Consultant Medical Geneticist. Direct insurance billing verification is also included.
3. How should I interpret a negative result from this test?
Answer: A negative result significantly reduces the likelihood of a DRD2-related genetic etiology but does not entirely exclude all hereditary forms of myoclonic dystonia. Other genes (e.g., SGCE, DYT1) may be implicated. Your geneticist will review the result in the context of your full clinical presentation and may recommend broader testing if clinically indicated.
UAE Regulatory & Data Privacy Adherence
Your Data, Our Commitment
DNA Labs UAE operates under the highest standards of clinical governance and data protection. This diagnostic service strictly complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ ensuring your genetic data is processed lawfully, transparently, and stored securely within UAE jurisdictions.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ governing the safe handling of electronic health records and telemedicine services.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ affirming your rights to informed consent and safe clinical practice throughout the diagnostic pathway.
- DHA & MOHAP Licensing Standards โ our facility holds DHA License No. 1143 and adheres to rigorous inspection protocols.
Clinical & Logistical Metadata
| Test Name | DRD2 Gene Sequencing for Myoclonic Dystonia (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV detection |
| ICD-10-CM Code | G24.8 (Other dystonia) / G25.8 (Other specified extrapyramidal and movement disorders) |
| LOINC Code | 50286-7 (DRD2 gene analysis) |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians